Parkinson's Disease Trial, Recruiting NCT07024875 Sponsor: Washington University School of Medicine Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07024875
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's Disease:

  • A person must have a formal clinical diagnosis of Parkinson's Disease
  • A person must not meet the criteria for a dementia diagnosis

For healthy volunteers (people without Parkinson's Disease):

  • A person must have a normal or near-normal neurological examination
  • A person must have normal cognitive (thinking and memory) functioning
  • A person must have no parents, siblings, or children who have been diagnosed with Parkinson's Disease

Who may not be able to join:

  • People who have a neurological condition other than Parkinson's Disease
  • People who have had a serious head injury involving loss of consciousness lasting more than 5 minutes, or a head injury that caused lasting neurological effects
  • People who have a diagnosis of schizophrenia, bipolar disorder, or epilepsy
  • People who have end-stage organ failure or are currently undergoing cancer treatment
  • People who have a diagnosis of dementia, or who score below a certain threshold on standard memory and thinking tests (confirm with trial site)
  • People who have metal implants in their body, experience claustrophobia (fear of enclosed spaces), or weigh over 300 pounds, as these factors may make MRI scanning unsafe or not possible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Evan Gordon, PhD, Washington University School of Medicine

Phone: 314-273-4429

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 January 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cortico-subcortical connectivity to SCAN vs effectors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov